News
Insights
Jobs
Career Advice
Companies
Hotbeds
More

SUBSCRIBE

SUBSCRIBE

News
Insights
Jobs
Career Advice
Companies
Hotbeds
More

Search Query

Search Results

Looking for jobs? Search jobs

17,249 Results

Type

Article (1107)
Company Profile (3)
Press Release (16139)

Section

Business (5135)
Career Advice (13)
Deals (1017)
Drug Delivery (4)
Drug Development (2025)
Employer Resources (4)
FDA (412)
Job Trends (239)
News (8666)
Policy (748)

Tag

Date

Today (2)
Last 7 days (9)
Last 30 days (33)
Last 365 days (691)
2025 (29)
2024 (706)
2023 (787)
2022 (2179)
2021 (2012)
2020 (1408)
2019 (1057)
2018 (706)
2017 (972)
2016 (799)
2015 (1043)
2014 (829)
2013 (745)
2012 (784)
2011 (695)
2010 (607)

Location

Africa (19)
Asia (771)
Australia (224)
California (38)
Canada (20)
Connecticut (8)
Europe (6885)
Florida (4)
Georgia (3)
Illinois (9)
Indiana (5)
Japan (6)
Maryland (4)
Massachusetts (36)
Michigan (5)
New Jersey (11)
New York (7)
North Carolina (9)
Northern California (20)
Pennsylvania (39)
South America (29)
Southern California (8)

Filters

Type

Article (1107)
Company Profile (3)
Press Release (16139)

Section

Business (5135)
Career Advice (13)
Deals (1017)
Drug Delivery (4)
Drug Development (2025)
Employer Resources (4)
FDA (412)
Job Trends (239)
News (8666)
Policy (748)

Tag

Date

Today (2)
Last 7 days (9)
Last 30 days (33)
Last 365 days (691)
2025 (29)
2024 (706)
2023 (787)
2022 (2179)
2021 (2012)
2020 (1408)
2019 (1057)
2018 (706)
2017 (972)
2016 (799)
2015 (1043)
2014 (829)
2013 (745)
2012 (784)
2011 (695)
2010 (607)

Location

Africa (19)
Asia (771)
Australia (224)
California (38)
Canada (20)
Connecticut (8)
Europe (6885)
Florida (4)
Georgia (3)
Illinois (9)
Indiana (5)
Japan (6)
Maryland (4)
Massachusetts (36)
Michigan (5)
New Jersey (11)
New York (7)
North Carolina (9)
Northern California (20)
Pennsylvania (39)
South America (29)
Southern California (8)

17,249 Results for "boehringer ingelheim gmbh".

Sort By

Collaboration

Boehringer Ingelheim Expands Cancer Pipeline With Back-to-Back Antibody Deals

On Thursday, Boehringer Ingelheim announced a partnership with Synaffix to advance antibody-drug conjugates and exercised its fourth license option under a 2013 collaboration with Oxford BioTherapeutics.

January 10, 2025
·
2 min read
·
Tristan Manalac
Schizophrenia

Boehringer Suffers Phase III Schizophrenia Fail, Legal Parry by HHS

Boehringer Ingelheim’s trio of late-stage schizophrenia failures on Thursday came a day after the Department of Health and Human Services hit back on the pharma’s legal challenge to the IRA’s drug price negotiation program.

January 17, 2025
·
2 min read
·
Tristan Manalac
Biosimilars

Boehringer Ingelheim Partners With GoodRx to Offer Humira Biosimilar at 92% Discount

In a bid to take advantage of Humira’s slow loss of market share, Boehringer Ingelheim is offering its biosimilar at a 92% discount exclusively to patients who buy the product on GoodRx.

July 19, 2024
·
2 min read
·
Tristan Manalac
Legal

Boehringer Ingelheim Loses Legal Challenge to IRA in Connecticut Federal Court Ruling

A federal judge ruled last week that the U.S. government can use its economic standing as a bulk purchaser to negotiate for better deals, handing Boehringer Ingelheim a loss in its legal challenge to the Inflation Reduction Act.

July 8, 2024
·
2 min read
·
Tristan Manalac
Business

PhoreMost Achieves Second Milestone in Target Discovery Alliance with Boehringer Ingelheim

PhoreMost Ltd., has triggered a second milestone payment in its multi-project target discovery collaboration with Boehringer Ingelheim.

June 3, 2024
·
2 min read
Business

New XSeed Labs Research Team Starts Activity in the U.S. in Collaboration With Boehringer Ingelheim

XSeed Labs - a collaboration between BioMed X and Boehringer Ingelheim, announces the start of its first research team on the Boehringer Ingelheim campus in Ridgefield, Connecticut.

May 16, 2024
·
3 min read
Press Releases

Boehringer Ingelheim Acquires Fourth License for the Development of Novel Antibody Based Cancer Treatments from Oxford BioTherapeutics

January 9, 2025
·
3 min read
Biotech Bay

Boehringer Ingelheim expands access to adalimumab-adbm injection, the company’s biosimilar to Humira®

Boehringer Ingelheim announced an agreement with Quallent Pharmaceuticals, a private label pharmaceutical distributor, to help expand patient access to citrate-free adalimumab-adbm, Boehringer’s biosimilar to Humira®, in the U.S.

May 13, 2024
·
11 min read
Drug Development

Zealand Pharma announces that Boehringer Ingelheim’s survodutide demonstrates breakthrough improvement in liver fibrosis with no worsening of MASH in 64.5% of patients with F2 and F3 fibrosis

Zealand Pharma announces that Boehringer Ingelheim’s survodutide demonstrates breakthrough improvement in liver fibrosis with no worsening of MASH in 64.5% of patients with F2 and F3 fibrosis

June 7, 2024
·
7 min read
Biotech Bay

Boehringer Ingelheim’s COPD and asthma inhalers are now available for $35 a month for eligible patients

Boehringer Ingelheim’s new program to cap out-of-pocket costs at $35 per month for eligible patientsi for the company’s inhalers is now available.

June 1, 2024
·
17 min read

1 of 1,725

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.

Explore
About
More

© 1985 - 2025 BioSpace.com. All rights reserved.

twitter
instagram
facebook
linkedin